Top Stories
-
In people with dementia, delirium during COVID-19 is more common but deaths from COVID-19 are not disproportionately higher, finds a new study.
Topic
-
New research may lead to the development of drugs to prevent the nerve damage and pain many cancer patients experience during chemotherapy.
Topic
-
Cells used to study the human blood-brain barrier in the lab aren’t what they seem, a new study has found, throwing nearly a decade’s worth of research into question.
Topic
-
A new Columbia study suggests that malfunctioning endosomes—a central trafficking station inside neurons—are commonly involved in the appearance of Alzheimer’s disease.
Topic
Latest News
- January 24, 2018
Clinical trial shows that solanezumab, an antibody-based treatment for Alzheimer’s disease, does not significantly slow cognitive decline.
Topic
- January 16, 2018
Columbia neurologists and engineers are using a robotic device to investigate how Parkinson’s affects the ability to walk and respond to balance perturbations.
Topic
- December 29, 2017
A community wellness center led by two P&S faculty members will strengthen initiatives in stroke prevention and mental health support.
Topic
- December 1, 2017
A new study finds that periodically reanalyzing epilepsy patients' DNA may aid in diagnosis and treatment.
Topic
- November 22, 2017
New video that reveals how immune cells breach the blood-brain barrier is giving scientists new ideas about treating multiple sclerosis.
Topic
- November 17, 2017
Researchers at Columbia University found that dementia is on the decline in seniors from northern Manhattan, following national trends.
Topic
- November 13, 2017
A new study suggests a smell test can identify people with mild cognitive impairment–often a precursor to Alzheimer’s–who may benefit from cholinesterase inhibitors.
Topic
- November 8, 2017
New Zika research from Columbia University suggests that high rates of microcephaly in Brazil were not caused by new mutations in the virus, as previously believed.
Topic
- October 3, 2017
Scientists propose a new model for Alzheimer's disease that may explain the high failure rate of recent clinical trials.
Topic
- September 18, 2017
A cellular defense against protein aggregates suppresses ALS in early stages but later hastens spread of the disease, a study in mice suggests.
Topic
